Literature DB >> 2404716

Five-year follow-up study on plasma insulin levels in newly diagnosed NIDDM patients and nondiabetic subjects.

L K Niskanen1, M I Uusitupa, H Sarlund, O Siitonen, K Pyörälä.   

Abstract

A representative group of middle-aged (45- to 64-yr-old) patients with non-insulin-dependent diabetes mellitus (NIDDM) (n = 133; 70 men, 63 women) were examined at the time of diagnosis and 5 yr afterward for metabolic control and insulin response to oral glucose; 144 nondiabetic control subjects (62 men, 82 women) were similarly examined twice between 5-yr intervals. At the 5-yr examination, 56 of the diabetic patients (36 men, 20 women) were on diet therapy only, 60 (27 men, 33 women) received oral antidiabetic drugs, and 5 were treated with insulin. The metabolic control of diabetic patients was poor at the time of diagnosis and 5-yr examination. Fasting plasma insulin levels were higher in diabetic patients than in control subjects both at baseline (23 +/- 2 vs. 14 +/- 1 mU/L, P less than 0.01, for men; 26 +/- 2 vs. 15 +/- 1 mU/L, NS, for women) and 5-yr examination (19 +/- 1 vs. 16 +/- 2 mU/L, NS, for men; 29 +/- 5 vs. 15 +/- 1 mU/L, P less than 0.05, for women). The frequency of insulin deficiency in diabetic patients based on a postglucagon (1 mg i.v.) C-peptide level less than 0.60 nM was 3.3% at the 5-yr examination, indicating that true insulin deficiency was uncommon during the first years after diagnosis of diabetes in middle-aged subjects.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2404716     DOI: 10.2337/diacare.13.1.41

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  8 in total

1.  Na+-sensitive elevation in blood pressure is ENaC independent in diet-induced obesity and insulin resistance.

Authors:  Jonathan M Nizar; Wuxing Dong; Robert B McClellan; Mariana Labarca; Yuehan Zhou; Jared Wong; Donald G Goens; Mingming Zhao; Nona Velarde; Daniel Bernstein; Michael Pellizzon; Lisa M Satlin; Vivek Bhalla
Journal:  Am J Physiol Renal Physiol       Date:  2016-02-03

2.  Relationship between C peptide and chronic complications in type-2 diabetes mellitus.

Authors:  Ramazan Sari; Mustafa Kemal Balci
Journal:  J Natl Med Assoc       Date:  2005-08       Impact factor: 1.798

3.  Therapeutic traditions in type 2 diabetes--are they changing?

Authors:  L Niskanen; H Enlund; V Jormanainen; A Nissinen; M Uusitupa
Journal:  Eur J Clin Pharmacol       Date:  1994       Impact factor: 2.953

4.  Effect of insulin on renal sodium handling in hyperinsulinaemic type 2 (non-insulin-dependent) diabetic patients with peripheral insulin resistance.

Authors:  P Skøtt; A Vaag; N E Bruun; O Hother-Nielsen; M A Gall; H Beck-Nielsen; H H Parving
Journal:  Diabetologia       Date:  1991-04       Impact factor: 10.122

5.  Defects in insulin secretion and insulin action in non-insulin-dependent diabetes mellitus are inherited. Metabolic studies on offspring of diabetic probands.

Authors:  I Vauhkonen; L Niskanen; E Vanninen; S Kainulainen; M Uusitupa; M Laakso
Journal:  J Clin Invest       Date:  1998-01-01       Impact factor: 14.808

6.  Ten-year cardiovascular mortality in relation to risk factors and abnormalities in lipoprotein composition in type 2 (non-insulin-dependent) diabetic and non-diabetic subjects.

Authors:  M I Uusitupa; L K Niskanen; O Siitonen; E Voutilainen; K Pyörälä
Journal:  Diabetologia       Date:  1993-11       Impact factor: 10.122

7.  Nerve function and its determinants in patients with newly-diagnosed type 2 (non-insulin-dependent) diabetes mellitus and in control subjects--a 5-year follow-up.

Authors:  J M Lehtinen; L Niskanen; K Hyvönen; O Siitonen; M Uusitupa
Journal:  Diabetologia       Date:  1993-01       Impact factor: 10.122

8.  Islet cell antibodies are associated with beta-cell failure also in obese adult onset diabetic patients.

Authors:  A Gottsäter; M Landin-Olsson; A Lernmark; P Fernlund; G Sundkvist
Journal:  Acta Diabetol       Date:  1994-12       Impact factor: 4.280

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.